EWJ Dec 2023 - Journal - Page 16
UK Patients set to Have Faster
Access to Innovative Medical
Technologies via New Pathway
The Innovative Devices Access Pathway (IDAP) pilot was launched by the
Department of Health and Social Care (DHSC), Health Technology Wales (HTW),
the Medicines and Healthcare products Regulatory Agency (MHRA), the National
Health Service England (NHSE), the National Institute for Health and Care
Excellence (NICE), the Office for Life Sciences (OLS), and the Scottish Health
Technologies Group (SHTG).
The IDAP, supported by £10 million of Government
funding, has the potential to expedite UK patient access to innovative technologies by providing innovators and manufacturers with multi-partner support
and targeted scientific advice.
l The development of a targeted product roadmap
The ambition of this new pathway is to support the
rapid development of innovative technologies that can
be introduced into the National Health Service (NHS)
to address unmet clinical needs for patients and
healthcare professionals at the earliest opportunity,
without compromising on standards of safety, quality,
and effectiveness. The pathway builds on the government’s intention to develop an end-to-end pathway
for innovation as set out in the Medical Technology
Strategy published on 3 February 2023 and delivers
on the ambitions set out in the Government’s Life
Sciences Vision.
l
l System navigation advice
l A priority clinical investigation
l Joint scientific advice with partners
Support with Health Technology Assessments
(HTA) for product realisation and adoption
l Safe-harbour meetings to discuss NHS adoption
Exceptional use authorisation granted by the
MHRA, provided necessary safety standards are met
l
David Lawson, Director of Medical Technology at the
Department of Health and Social Care, said:
Today’s launch marks an important step forward in
the implementation of the Medical Technology Strategy published in February this year. It signals our
commitment to move towards a rules-based pathway
which will ensure the adoption of specialty innovative
medical technology into the NHS, helping to benefit
patient outcomes. The IDAP showcases our internationally respected regulatory and guidance bodies and
the tailored support on offer for technologies that
meet the specific needs of the NHS.
Following announcement of the IDAP on 25 May
2023, today the government launched the pilot phase
and innovators are invited to submit Expressions of
Interest for access into the pathway.
Throughout the pathway the partners will offer
targeted support to successful applicants which may
include:
EXPERT WITNESS JOURNAL
14
DECEMBER 2023